The IPO will consist of a fresh issue of ₹1,160 crore and an offer for sale of up to 7.31 million shares by parent Glenmark Pharmaceuticals Ltd …
( read original story …)
The Japan News
The IPO will consist of a fresh issue of ₹1,160 crore and an offer for sale of up to 7.31 million shares by parent Glenmark Pharmaceuticals Ltd …
( read original story …)